"When I found out I had cancer, there were two things could do: quit or keep pounding," Mills said. "I'm a fighter. I kept pounding. You're fighters, too. Keep pounding!"
https://t.co/CQzc68pIT3
#keeppounding#LevineCancer
Multiple Myeloma Research Foundation 5K Walk/Run
October 22, 2022
Clanton Park
Charlotte NC
Please consider helping the MMRF to accelerate faster and smarter cures for every myeloma patient.
https://t.co/rgYGd5gF4n
One of my favorite details so far in the #obiwankenobi show is the reveal that Ben bought a fixed the t16 sky hopper toy that we see Luke playing with in new hope. As a Star Wars fan I love seeing these classic moments expanded upon through all these new shows. #starwars
#HemOnc#HCPs: do your patients living with #myeloma know the phrase minimal residual disease? Perhaps they’ve heard you say it but don’t know what it means. Share this video, which breaks it all down in patient-friendly terms #mmsm
Multiple myeloma is the most common blood cancer in the Black community. Knowing your family history is important. Early detection is key to saving lives! Please share this post, including the hashtag #BlackFamCan, to help raise awareness! Learn more here: https://t.co/1pugzr4Pht
June 16-22 is National Black Family Cancer Awareness Week. Multiple myeloma is the most common blood cancer among African Americans, who have a greater-than-average risk of developing the disease. #BlackFamCan
#DYK: incidence of myeloma is more than 2 times higher in Black people compared to White people. This week, we’re sharing the @US_FDA's second annual National Black Family Cancer Awareness Week, which raises awareness of the health inequities in #bloodcancer. #BlackFamCan
Multiple Myeloma (MM) has one of the greatest disparities in incidence and prevalence of hematologic malignancies, with incidence in Black patients more than twice that in white patients. Listen in to learn how to approach MM with cultural consciousness https://t.co/Gvh2NDIsHw
New innovative class of immunotherapy drugs - trispecific antibodies (targeting 3 antigens) - is opening up in myeloma care. We have it at Myeloma Program at @SylvesterCancer in Miami. For patients with relapsed/refractory myeloma. #mmsm@myelomacrowd@IMFmyeloma@theMMRF
The #COVID19 pandemic has raised many questions, especially around vaccination.
Read here this Q&A to answer some of the most frequently asked questions about the current approved vaccines and treatments in Europe.
https://t.co/cSTO4ySvuF
One of our Pt got the car T cell for myeloma under @szusmani a wonderful human being and great doctor. Thanks for taking care of him. Thanks to ur staff and all those involved in making this a reality @MSKCancerCenter
The #MyelomaMinute is out! Read and subscribe. This week we feature the 2022 Brian D. Novis Research Grants, the latest results of the Phase 3 IKEMA trial, upcoming events, and Dr. Durie answers a patient's question.
https://t.co/VX5nzALNhw
👩⚕️ Today we’re celebrating International Clinical Trial Awareness Day!
The world’s first clinical trial was developed by James Lind on May 20th all the way back in 1747 to evaluate the effectiveness of citrus fruits against scurvy. Can you believe that?! 🍋 🌊
We have factsheets for patients and patient advocates that cover the main issues regarding treatment updates.
Click on the link to check out the new factsheets about #Selinexor, #Isatuximab and #IdecabtageneVicleucel
https://t.co/jvhTiWdf9d
On 5/24, Dr. Ian Flinn is chairing "Institutional Perspectives in Cancer: Multiple Myeloma & Leukemia/Lymphoma" webinar and Live Q&A with @OncLive. You will not want to miss this virtual event! Register below:
https://t.co/OCRpac52id
Don’t miss the @permedcoalition Personalized Medicine Conference. Our CEO Michael Andreini and @gnshealthcare CEO @ColinHill1 will discuss patient-specific models of disease progression and drug response using data from the #MMRF CoMMpass Study. More here: https://t.co/68FVaaP5Kv
Happening now!
A discussion about the latest developments in Multiple Myeloma from Global Leader & Chief Medical Officer at the International Myeloma Foundation-- Dr. Joseph Mikhael. @jmikhaelmd@IMFmyeloma
Youtube: https://t.co/ZqJiqerFJA
CH: https://t.co/6ZIOBQKIqc